MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
NVIDIA
NVDA
US Stock MarketDetailed Quotes
ELTX Elicio Therapeutics
- 5.620
- +0.480+9.34%
Close Jan 3 16:00 ET
60.65MMarket Cap-1.29P/E (TTM)
5.657High5.140Low48.26KVolume5.430Open5.140Pre Close261.16KTurnover0.57%Turnover RatioLossP/E (Static)10.79MShares11.45052wk High-3.19P/B47.27MFloat Cap2.96052wk Low--Dividend TTM8.41MShs Float263.000Historical High--Div YieldTTM10.06%Amplitude2.960Historical Low5.411Avg Price1Lot Size
Elicio Therapeutics News
Elicio Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Venkatesan Jay
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DeMuth Peter
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WILSON KAREN J
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ADAMS JULIAN
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ashe Carol Gail
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RUFFOLO ROBERT R
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chudnovsky Yekaterina
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nissenson Allen
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Connelly Robert
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DeMuth Peter
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Haqq Christopher
Elicio Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yekaterina Chudnovsky(38.7%),GKCC, LLC(38.7%)
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chudnovsky Yekaterina
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay
Elicio Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yekaterina Chudnovsky(19.99%),GKCC, LLC(19.95%)
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chudnovsky Yekaterina
Elicio Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Elicio Therapeutics | D: Filing D
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.